drugset / Trial / NCT06061393

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

NCT06061393 ↗

Phase 4 Recruiting 200 enrolled Western Galilee Hospital-Nahariya
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.

Timeline

Start
2023-11-02
Primary completion
2027-09
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferinject Unknown 500 mg —
Comparator Iron sucrose Unknown 200 mg —